All In MedTech

Device Trial Radar · NCT06127199

Contraceptive Efficacy Study of Ovaprene

A Single Arm, Open-Label Pivotal Contraceptive Efficacy Study of Ovaprene

Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingTitle says "pivotal". This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

656

Planned (sponsor's estimate)

Start

Dec 19, 2023

Primary completion

Apr 30, 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Daré Bioscience, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
First posted
Nov 13, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Prevention
FDA-regulated device
Yes
Who can join
Female only, from 18 years, up to 40 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This will be a multi-center, single arm, open-label study of Ovaprene, a non-hormonal intravaginal ring, to investigate the contraceptive effectiveness, safety and acceptability of Ovaprene.

Conditions

  • Contraception

Interventions

  • OvapreneDevice

    Non-hormonal intravaginal ring

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determination of pregnancy rateTime frame: 12 months

Locations

27 sites in 1 country. Site status is shown where the registry gives one.

  • Precision Trials AZ

    Phoenix, Arizona · Recruiting

  • MomDoc Women's Health Research

    Scottsdale, Arizona · Completed

  • Del Sol Research Management, LLC

    Tucson, Arizona · Recruiting

24 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.